scholarly journals Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease

Author(s):  
Roger K. Prichard
Author(s):  
Cristina Ballesteros ◽  
Cassan N. Pulaski ◽  
Catherine Bourguinat ◽  
Kathy Keller ◽  
Roger K. Prichard ◽  
...  

2017 ◽  
Vol 246 ◽  
pp. 76-81 ◽  
Author(s):  
Christopher C. Evans ◽  
Andrew R. Moorhead ◽  
Bobby E. Storey ◽  
Byron L. Blagburn ◽  
Adrian J. Wolstenholme ◽  
...  

2015 ◽  
Vol 210 (3-4) ◽  
pp. 167-178 ◽  
Author(s):  
Catherine Bourguinat ◽  
Alice C.Y. Lee ◽  
Regina Lizundia ◽  
Byron L. Blagburn ◽  
Janice L. Liotta ◽  
...  

Parasitology ◽  
2015 ◽  
Vol 142 (10) ◽  
pp. 1249-1259 ◽  
Author(s):  
ADRIAN J. WOLSTENHOLME ◽  
CHRISTOPHER C. EVANS ◽  
PABLO D. JIMENEZ ◽  
ANDREW R. MOORHEAD

SUMMARYPrevention of heartworm disease caused by Dirofilaria immitis in domestic dogs and cats relies on a single drug class, the macrocyclic lactones (MLs). Recently, it has been demonstrated that ML-resistant D. immitis are circulating in the Mississippi Delta region of the USA, but the prevalence and impact of these resistant parasites remains unknown. We review published studies that demonstrated resistance in D.immitis, along with our current understanding of its mechanisms. Efforts to develop in vitro tests for resistance have not yet yielded a suitable assay, so testing infected animals for microfilariae that persist in the face of ML treatment may be the best current option. Since the vast majority of D. immitis populations continue to be drug-sensitive, protected dogs are likely to be infected with only a few parasites and experience relatively mild disease. In cats, infection with small numbers of worms can cause severe disease and so the clinical consequences of drug resistance may be more severe. Since melarsomine dihydrochloride, the drug used to remove adult worms, is not an ML, the ML-resistance should have no impact on our ability to treat diseased animals. A large refugium of heartworms that are not exposed to drugs exists in unprotected dogs and in wild canids, which may limit the development and spread of resistance alleles.


2020 ◽  
Vol 283 ◽  
pp. 109125 ◽  
Author(s):  
Julie Sanchez ◽  
Guha Dharmarajan ◽  
Melissa M. George ◽  
Cassan Pulaski ◽  
Adrian J. Wolstenholme ◽  
...  

2011 ◽  
Vol 181 (2-4) ◽  
pp. 388-392 ◽  
Author(s):  
Catherine Bourguinat ◽  
Kathy Keller ◽  
Aron Bhan ◽  
Andrew Peregrine ◽  
Timothy Geary ◽  
...  

2011 ◽  
Vol 182 (2-4) ◽  
pp. 380-381
Author(s):  
Catherine Bourguinat ◽  
Aron Bhan ◽  
Andrew Peregrine ◽  
Timothy Geary ◽  
Roger Prichard

Parasitology ◽  
2007 ◽  
Vol 134 (8) ◽  
pp. 1111-1121 ◽  
Author(s):  
S. McCAVERA ◽  
T. K. WALSH ◽  
A. J. WOLSTENHOLME

SUMMARYLigand-gated chloride channels, including the glutamate-(GluCl) and GABA-gated channels, are the targets of the macrocyclic lactone (ML) family of anthelmintics. Changes in the sequence and expression of these channels can cause resistance to the ML in laboratory models, such as Caenorhabditis elegans and Drosophila melanogaster. Mutations in multiple GluCl subunit genes are required for high-level ML resistance in C. elegans, and this can be influenced by additional mutations in gap junction and amphid genes. Parasitic nematodes have a different complement of channel subunit genes from C. elegans, but a few genes, including avr-14, are widely present. A polymorphism in an avr-14 orthologue, which makes the subunit less sensitive to ivermectin and glutamate, has been identified in Cooperia oncophora, and polymorphisms in several subunits have been reported from resistant isolates of Haemonchus contortus. This has led to suggestions that ML resistance may be polygenic. Possible reasons for this, and its consequences for the development of molecular tests for resistance, are explored.


Sign in / Sign up

Export Citation Format

Share Document